In the same ALL study as described above, Dahlhaus et al. also found that miR-142 was mostly expressed at higher levels in AML cell lines and 29 AML patient peripheral blood or bone marrow samples compared to CD34+ hematopoietic stem cells from healthy donors [201]. The gene discussed is CD34; the disease is acute myeloid leukemia.